GlassScriptPhysician profile
Isabel M Mccormick
NPI 1619003738
$3,058.31
in general payments reported to CMS, 2019-2025
19 companies · $759 in 2025
The $759 reported for 2025 was more than what 80% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $301 · 2022: $772 · 2023: $529 · 2024: $698 · 2025: $759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,985.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,985.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $669.59 | 2022-2025 | Fasenra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $354.29 | 2024-2025 | Jardiance |
| Gilead Sciences, INC. | $242.13 | 2023-2025 | Epclusa, Descovy |
| Acadia Pharmaceuticals INC | $239.40 | 2022 | |
| Amgen INC. | $203.25 | 2024-2025 | Repatha, Repatha |
| Urovant Sciences INC | $187.80 | 2021-2022 | |
| Averitas Pharma INC. | $124.99 | 2023 | Qutenza |
| Pfizer INC. | $124.74 | 2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $124.68 | 2022 | |
| Lilly USA, LLC | $120.83 | 2023 | Mounjaro |
| Teva Pharmaceuticals USA, INC. | $116.38 | 2024 | Austedo Xr |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.20 | 2022 | |
| Laborie Medical Technologies Corp. | $93.12 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Inspire Medical Systems, INC. | $90.25 | 2023 | Inspire |
| Insmed, INC. | $86.62 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $77.00 | 2021 | |
| Abbott Laboratories | $67.66 | 2023 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $19.31 | 2021 | |
| Grt US Holding, INC. | $17.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isabel Mccormick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.